FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to the novel agent of the general formula (I) : R1-R6 where preferable radicals are the following: each of R1 and R3 means alkyl-group that can be substituted with halogen atom, amino-group, hydroxyl-group, alkoxyl-group or thiol group; hydrogen atom, halogen atom or alkoxyl-group; R3 means hydrogen atom; R4 means methyl-group; R5 means hydrogen atom or alkyl-group and R6 means the group of the formula: where Z is phenyl-group. Compound shows an antitumor activity. Invention relates to also the antitumor agent based on said. EFFECT: valuable pharmacological property of compound. 10 cl, 2 tbl, 42 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
AROMATIC AMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2139851C1 |
PIPERIDINE DERIVATIVE | 2008 |
|
RU2475485C2 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS | 1994 |
|
RU2141946C1 |
VLA-4 INHIBITORS | 2001 |
|
RU2290403C2 |
AMINOPROPYLIDENE DERIVATIVES | 2009 |
|
RU2483063C2 |
1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR | 1994 |
|
RU2124517C1 |
DIAZABICYCLOALKENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2126008C1 |
DERIVATIVES OF ANTHRANILIC ACID OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS USED FOR THEIR SYNTHESIS AND DRUG | 1994 |
|
RU2128644C1 |
TETRAHYDROCARBOLINE DERIVATIVE | 2011 |
|
RU2572818C2 |
Authors
Dates
2000-03-20—Published
1995-09-25—Filed